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Abstract
Background: Existing scientific literature is a rich source of biological information such as disease
markers. Integration of this information with data analysis may help researchers to identify possible
controversies and to form useful hypotheses for further validations. In the context of proteomics
studies, individualized proteomics era may be approached through consideration of amino acid
substitutions/modifications as well as information from disease studies. Integration of such
information with peptide searches facilitates speedy, dynamic information retrieval that may
significantly benefit clinical laboratory studies.
Description:  We have integrated from various sources annotated single amino acid
polymorphisms, post-translational modifications, and their documented disease associations (if they
exist) into one enhanced database per organism. We have also augmented our peptide
identification software RAId_DbS to take into account this information while analyzing a tandem
mass spectrum. In principle, one may choose to respect or ignore the correlation of amino acid
polymorphisms/modifications within each protein. The former leads to targeted searches and
avoids scoring of unnecessary polymorphism/modification combinations; the latter explores
possible polymorphisms in a controlled fashion. To facilitate new discoveries, RAId_DbS also allows
users to conduct searches permitting novel polymorphisms as well as to search a knowledge
database created by the users.
Conclusion: We have finished constructing enhanced databases for 17 organisms. The web link
to RAId_DbS and the enhanced databases is http://www.ncbi.nlm.nih.gov/CBBResearch/qmbp/
RAId_DbS/index.html. The relevant databases and binaries of RAId_DbS for Linux, Windows, and
Mac OS X are available for download from the same web page.
Introduction
Scientific literature, documenting different studies and
conclusions, is among the most important sources of
knowledge and biological information. It has been noted
[1,2] that it is in the scientific community's best interest to
be able to have such information consolidated and organ-
ized in an easy-to-use format so that researchers can inte-
grate and/or interrogate the existing knowledge during
biological data analysis. Such a knowledge integration
may help researchers in identifying conflicting results [3],
forming new hypotheses, and performing experimental
validations. In the scope of proteomics studies to which
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we now turn, information related to single amino acid
polymorphisms (SAPs) and post-translational modifica-
tions (PTMs) is among the most important.
Like single nucleotide polymorphisms (SNPs) that occur
roughly every 300 base pairs [4], SAPs also differentiate
individuals from one another. It is well known that SNPs
may result in SAPs that are not yet annotated and thus not
present in the standard protein databases. To enable iden-
tification of peptides containing this type of SAPs,
Edwards [5] had come up with a compression scheme to
reduce the size of the expressed sequence tag (EST) data-
base to allow searches within the compactified database.
In addition to resulting from nonsynonymous SNPs,
however, SAPs may also occur due to post-transcriptional
regulations such as mRNA editing [6]. SAPs together with
PTMs are often used as disease markers [7-10]. Integration
of this annotated, disease-related knowledge with data
analysis facilitates speedy, dynamic information retrieval
that may significantly benefit clinical laboratory studies.
To incorporate existing knowledge and information
within peptide searches, we start by constructing a human
protein database where information about annotated
SNPs, SAPs, PTMs, and their disease associations (if any)
are integrated. Consequently, the database part of our
work may be considered an advancement of references
[11] and [12]. The former extended the human protein
database to include SAPs but without PTMs and without
integration of disease information, while the latter allows
for protein-specific annotated PTMs but without SAPs and
without integration of disease information. We have also
modified our peptide identification software RAId_DbS
[13] to take into account the integrated information of
annotated SAPs/PTMs and diseases while performing pep-
tide searches. It is perceivable that the disease marker
within a protein might be manifested as specific combina-
tions of SAPs/PTMs, which we term information correla-
tion. As explained in the caption of Figure 1, our database
construction can easily accommodate correlations of this
type. To further facilitate new discoveries, RAId_DbS
allows users to conduct searches permitting novel SAPs.
However, it is worth pointing out that allowing annotated
SAPs/PTMs (or novel SAPs) during the search, one is deal-
ing with a larger search space than before and thus should
anticipate an increase (decrease) in false positives
(retrieval efficiency). Therefore, we recommend the users
to turn on annotated SAPs/PTMs and novel SAPs only if
the regular searches returns no significant hit. Specifically,
we recommend the users to perform regular searches first.
For spectra that do not receive any significant hit from reg-
Information-preserved protein clustering example Figure 1
Information-preserved protein clustering example. Once a consensus sequence is selected, members of a cluster are 
merged into the consensus one-by-one. This figure illustrates how the information of a member sequence is merged into the 
consensus sequence. Amino acid followed by two zeros indicates an annotated SAP. Every annotated PTM has a two-digit pos-
itive integer that is used to distinguish different modifications. The difference in the primary sequences between a member and 
the consensus introduces cluster-induced SAPs. In this example, the residues Q and A (in red) in the consensus are different 
from the residues K and V (in blue) in the member sequence. As a consequence, K becomes a cluster-induced SAP associated 
with Q and V becomes a cluster-induced SAP associated with A. The annotated SAP, 7{W00}8, associated with residue R in 
the member sequence is merged into the consensus sequence, see the updated consensus sequence in the figure. Note that 
the annotated PTM, 7(N11)8, associated with N in the member sequence is merged with a different annotated PTM, 7(N08)8, 
at the same site of the consensus sequence. In this figure, all the merged information from the member sequence are shown in 
blue color to indicate that during the searches we can choose to respect the correlated information from each member 
sequence separately. To respect the correlated information means that when scoring the peptide segment LQ 7{K00}8 RLVA 
7{V00}8 DR of the consensus sequence RAId_DbS only considers the combinations L(red Q)RLV(red A)DR and L(blue 
K)RLV(blue V)DR, but not L(red Q)RLV(blue V)DR and L(blue K)RLV(red A)DR. Having the choice to distinguish the SAPs/
PTMs originated from individual member sequences, RAId_DbS can target on documented SAP/PTM combinations associated 
with certain disease (if it exists) and can avoid scoring unnecessary SAP/PTM combinations when there are several variable 
sites occurring within a peptide. However, currently we find almost no incidence of multiple variable sites within a short pep-
tide in all our databases constructed. Therefore, the feature of respecting correlated information is only implemented in our 
in-house version, not yet in the web version. Furthermore, not forcing the integrity of correlated information also allows for 
novel SAP discovery in a controlled fashion, meaning that one is looking for SAPs with local precedence. Finally, let us empha-
size that although the SAPs, PTMs are merged each annotation's origin and disease associations are kept in the processed defi-
nition file, allowing for faithful information retrieval at the final reporting stage of the RAId_DbS program.
consensus seq. ...DPR.........KLQRLVADRN (N08) GSE ...
member seq. ...DPR {W00} ...KLKRLVVDRN (N11) GSE ...
updated consensus seq. ...DPR {W00} ...KLQ {K00} RLVA {V00} DRN (N08,N11) GSE...BMC Genomics 2008, 9:505 http://www.biomedcentral.com/1471-2164/9/505
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ular searches, one may turn on annotated SAPs/PTMs and
then search again. Finally, for spectra that receive no sig-
nificant hit from both regular searches and searches with
annotated SAPs/PTMs, one may turn on the novel SAPs
together with annotated SAPs/PTMs and then search
again.
We have built a web-based application taking query spec-
trum online as well as prepared standalone downloadable
executables that can be installed locally on users' own
machines. An important feature of the standalone version
is the flexibility for users to add SAP and/or PTM informa-
tion to various proteins they are interested in and even to
create a user-specific database that contains new protein
sequences. In the next section, we describe our database
construction to illustrate how we accommodate the SAPs,
PTMs, and their disease associations. We then provide a
brief introduction to our software RAId_DbS and elabo-
rate on its augmentation. In the result section, we use a
few examples to show the structure of our database. The
optimal use of our enhanced database in information
retrieval is sketched in the discussion section.
Database Construction
In the following discussion, we use human database con-
struction as an example to illustrate how we enhance the
protein databases. Similar procedures are employed to
construct enhanced databases of other organisms, see
Table 1 for a summary. We extracted 34,197 human pro-
tein sequences with a total of 16,814,674 amino acids
from the flat file (last updated 09/05/2006)
ftp:ftp.ncbi.nlm.nih.gov/genomes/H_sapiens/proteipro-
tein.gbk.gz. Included in this file are proteins and their
associated annotations generated respectively through the
Reference Sequence and the Genome Annotation projects
of the National Center for Biotechnology Information
(NCBI). Each protein sequence is accompanied by a list of
annotated SAPs and PTMs. Out of the 34,197 proteins, we
found 29,979 unique proteins with a total of 15,324,913
amino acids. To avoid having multiple copies of identical
or almost identical proteins in the database without los-
ing information, we first perform an information-preserved
clustering on the 34,197 sequences.
Information-Preserved Clustering (redundancy removal)
This process starts with an all-against-all BLAST [14]
among the 34,197 sequences. Two sequences with identi-
cal lengths and aligned gaplessly with less than 2% mis-
matches are clustered, and each sequence is called a
qualified hit of the other. Any other sequence that satisfies
this condition with a member of an existing cluster is
assigned to that existing cluster. All the annotations in the
same cluster are then merged. We find it possible for every
given cluster to choose a consensus sequence that will
make all other members its polymorphous forms. Hence,
we only retain one protein sequence for each of the
29,272 clusters finally obtained. The total number of
amino acids associated with these 29,272 consensus pro-
teins is 15,001,326. Although we only retain one
sequence (the consensus sequence) per cluster, the infor-
mation of other member sequences is still kept. For exam-
ple, when a member sequence and the consensus
Table 1: Summary of Enhanced Organismal Databases Searchable by RAId_DbS
Organism DB_name Protein NP NM SP SAPs PTMs DB_size (byte)
Homo sapiens hsa 29284 35059 35031 15030 116073 84406 16,265,018
Anopheles gambiae angam 12388 12719 12706 112 350 50 6,042,277
Arabidopsis thaliana artha 29651 31740 31711 5527 5207 11977 12,318,213
Bos taurus botau 23796 26504 26491 3979 3295 15810 11,188,490
Caenorhabditis elegans caele 22563 23097 23097 2890 1045 7756 10,050,609
Canis familiaris cafam 31705 33834 33821 528 2766 4196 18,458,474
Danio rerio darer 31192 36150 36137 1552 7358 3841 14,477,794
Drosophila melanogaster drmel 17232 20207 20207 2568 5611 9290 9,796,785
Equus caballus eqcab 17300 17637 17624 171 485 1045 9,404,150
Gallus gallus gagal 18154 18724 18681 1455 1109 6522 8,728,501
Macaca mulatta mamul 32547 38141 38128 207 1370 1262 14,498,187
Mus musculus mumus 28506 35503 35451 12170 27614 61684 14,363,491
Oryza sativa orsat 26636 26784 26777 1205 1291 2182 10,679,924
Pan troglodytes patro 41464 52130 52117 482 3721 3734 20,217,986
Plasmodium falciparum plfal 5240 5267 5267 88 56 184 3,995,386
Rattus norvegicus ranor 28914 39425 39389 5569 9297 33240 15,879,569
Saccharomyces cerevisiae sacer 5699 5880 0 5807 5507 13220 2,927,330
The header abbreviations in this table are explained as follows. The second column, headed by DB_name, documents the abbreviated database 
name for searches using standalone version of RAId_DbS. The column headed by "Protein" indicates the final number of protein clusters in the 
processed organismal databases. The columns headed by NP, NM, and SP summarize the breakdown of the total number of accession numbers 
included respectively from protein products, transcript products, and SwissProt protein entries. The columns headed by SAPs and PTMs indicate 
respectively the total number of annotated SAPs and PTMs included. The last column shows the database size in bytes.BMC Genomics 2008, 9:505 http://www.biomedcentral.com/1471-2164/9/505
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sequence disagree at two sites, the presence of the member
sequence is documented by introducing two cluster-
induced SAPs at the two sites of the consensus sequence.
The originally annotated SAPs and PTMs of the member
sequence are also merged into those of the consensus
sequence. Figure 1 and its caption illustrate how this proc-
ess is done iteratively. In our processed definition file (see
Table 2 for an example), each SAP or PTM is documented
with its origin. SAPs arising from clustering are easily dis-
tinguished from annotated SAPs. For member sequences
that are identical to the consensus sequence, the accession
numbers of those member sequences are also recorded
with their SAPs/PTMs annotations merged into the con-
sensus sequence. When a user selects not to have anno-
tated SAPs, RAId_DbS still allows for cluster-induced SAPs
resulting in an effective search of the original databases
but with minimum redundancy. The strategy employed
by RAId_DbS to search for SAPs and PTMs will be briefly
described in the "RAId_DbS and its Augmentation" sec-
tion below.
Ref_Seq Accession Number Retrieval
The consensus protein in a given cluster is then used as a
query to BLAST against the NCBI's nr database to retrieve
its RefSeq accession number and its corresponding Swiss-
Prot http://ca.expasy.org/sprot/ accession number, if it
exists, from the best qualified hit. It is possible for a cluster
to have more than one accession number. This happens
when there is a tie in the qualified best hits and when a
protein sequence in nr actually is documented with more
than one accession number.
Criteria for Inclusion of SAPs and PTMs
To minimize inclusion of less confident annotations, we
only keep the SAPs and PTMs that are consistently docu-
mented in more than one source. For example, for pro-
teins with Swiss-Prot accession numbers, we only keep the
SAPs and PTMs that are present both in Swiss-Prot [15]
and GenBank [16]. For proteins without Swiss-Prot acces-
sion numbers, the retentions of SAPs and PTMs are
described below. The PTM annotations are kept only if
they are present in the gzipped document
HPRD_FLAT_FILES_090107.tar.gz of the Human Protein
Reference Database http://www.hprd.org. The SAP anno-
tations are kept only if they are in agreement with the mas-
ter table, SNP_mRNA_pos.bcp.gz (last updated 01/10/
2007), of dbSNP: ftp://ftp.ncbi.nlm.nih.gov/snp/organ
isms/human_9606/database/organism_data. Even
though in many cases the primary information sources
might be identical, the curation protocols may differ
resulting in inconsistent annotations that are removed by
our filtering strategy.
Table 2: Example entries of the processed definition file
>NP_ 775259,NM_173167, Q8IWX7
60 I00 SAP gTC → A |NM_173167| dbSNP : 16970659
60 I00 SAP v → I |Q8IWX7| V → I (dbSNP : 16970659): FTId = V AR_ 027506
199 V 00 SAP GcA → T |NM_173167| dbSNP : 35749208
377 R00 SAP AaG → G |NM_173167| dbSNP : 41389545
496 H00 SAP d → H |Q8IWX7| D → H (breast cancersomatic mutation). FTId = VAR_035870
778 Q00 SAP CgG → A |NM_173167| dbSNP : 34242925
852 N00 SAP AtC → A |NM_173167| dbSNP : 11654824
852 N00 SAP i → N |Q8IWX7| I → N (dbSNP : 11654824). FTId = V AR_027507
>NP_076410,NM_023921,Q9NY W0
92 N08,N09, N10, N11,N12 PTM Nlinked(GlcNAc...) |Q9NY W0| N – linked(GlcNAc...)(Potential)
156 M00 SAP AcG → T |NM_023921| dbSNP : 597468
156 M00 SAP m → T |Q9NY W0| M → T (dbSNP : 597468) FTId = V AR_030009
156 M00 SAP t → M |NP_076410| Alignment with Q9NY W0
158 N08,N09,N10, N11,N12 PTM Nlinked(GlcNAc...) |Q9NY W0| N – linked(GlcNAc...)(Potential)
Two sequence clusters are shown in this table to demonstrate the structure of our processed information file. The text line after the ">" symbol 
contains accession numbers associated with the members of the cluster. The other rows each contains six entries separated by tabs. The first 
column indicates the residue position. The second column indicates the modified residue(s) that can occur at the position specified in the first 
column. The third column, labeled by either SAP or PTM, indicates the modification type. The fifth column contains the accession number of the 
source of modification, this may be a protein sequence or a mRNA. The fourth column explains the origin of the modification; a lower case letter 
indicates residue content in the source sequence, the upper case letter indicates the modified residue in the variant sequence. The notation, v → I, 
indicates the source sequence with amino acid V can change into I, ie, a SAP. The notation, gTC → A, is a short hand for codon change from gtc to 
atc, ie, a SNP that changes the coded amino acid from V to I as well. The sixth column contains additional information for the fourth column. It may 
include disease information or database entry index. As an example, in the first row of the first cluster, we have dbSNP : 16970659 indicating this 
SNP comes from the NCBI's dbSNP with entry index 16970659. In the fifth row, the sixth column contains disease origin. The additional Feature 
Identifier (FTId), VAR_xxxxxx, is the variant sequence documented by SwissProt. In the second cluster, fourth row, we see in the sixth column 
"Alignment with Q9NYW0", indicating that this SAP comes from the mismatch in the alignment between protein sequences in the clustering 
procedure. In the first and the last row of the second cluster, the second column contains N08, N09,..., N12, all of which are possible post-
translational modifications associated with Glycosylations [22] as indicated in the sixth column.BMC Genomics 2008, 9:505 http://www.biomedcentral.com/1471-2164/9/505
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RAId_DbS and its Augmentation
The web interface of RAId_DbS is shown in Figure 2. An
example of the reported peptide list resulting from a
search is shown in Figure 3. Note that the Goodness-of-fit
of the score model is reported. Basically, it represents how
well the score model, be theoretically derived or assumed,
agrees with the cumulated score histogram. Also reported
is a quantity called the model P-value, which documents
the likelihood for the correlation strength between the
model score distribution and the score histogram to come
RAId_DbS web interface Figure 2
RAId_DbS web interface. The link to this webpage is http://www.ncbi.nlm.nih.gov/CBBResearch/qmbp/RAId_DbS/
index.html. Enhanced databases for different organisms can be selected in the dropdown list.
File name (.DTA format):  Browse...
Database:  Homo sapiens
Choose enzyme type:  Trypsin (K,R)
Terminal group molecular weight (Da): 
N-terminal  1.007825
C-terminal  17.00274   
Bounds in the charge state of the precursor ion, allowed range [1,9]: 
(If both bounds set to 0 - charge state will be extracted from MS/MS file). 
Lower bound  0
Upper bound  0
Mass tolerance (Da), allowed range (0,1], effective range 3xMT:
Parent ion  1.0
Daughter ion 0.2
Cysteine modification:  Cysteine (103.009186 Da)
Series to score:   a  g f e d c  b g f e d c b  c g f e d c  b-NH3 g f e d c  b-H2O  g f e d c  b2 g f e d c
 x  g f e d c  y  g f e d c b  z  g f e d c  y-NH3 g f e d c  y-H2O  g f e d c  y2 g f e d c
Novel SAP:  do not search
Number of allowed annotated SAPs,
allowed range [0,2]:   per peptide  1
Number of allowed annotated PTMs,
allowed range [0,5]:   per peptide  2
Submit a JobBMC Genomics 2008, 9:505 http://www.biomedcentral.com/1471-2164/9/505
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out of random matching. Readers are referred to reference
[13] for details.
RAId_DbS Statistics
Here we briefly explain the underpinning of RAId_DbS
statistics and RAId_DbS's strategy to deal with searches in
different effective database sizes. The latter strategy can be
generalized to handle effective database size expansion
due to inclusion of SAPs and PTMs. Taking into account
the finite sample effect and the skewness of peak intensity
distribution, the form of asymptotic score statistics (P-val-
ues) of RAId_DbS [13] is derived theoretically. Since the
skewness varies per spectrum, the theoretically determined
parameters for our derived distribution are spectrum-spe-
cific. For most spectra considered, our theoretical distribu-
tions (used to compute P-values) agree well with the score
histograms accumulated. The final E-value for each pep-
tide hit in a search, however, is obtained by multiplying
the peptide's P-value by the number of peptides of its cat-
egory. As a specific example, when trypsin is used as the
digesting enzyme, RAId_DbS allows for incorrect N-termi-
nal cleavages. RAId_DbS has internal counters, Cc and Cinc,
totaling respectively the number of scored peptides with
correct and incorrect N-terminal cleavage. In general, Cinc
Ŭ Cc. When calculating the E-value of a peptide with cor-
rect N-terminal cleavage, RAId_DbS multiplies the pep-
tide's P-value by Cc. However, the E-value of a peptide
with incorrect N-terminal cleavage will be obtained by
multiplying the peptide's P-value by Cc + Cinc [13]. In line
with the Bonferroni correction that is rooted in the Bon-
ferroni inequality [17], our approach avoids overstating
the significance of a hit from a larger effective database
The Format of Search Results Reported by RAId_DbS Figure 3
The Format of Search Results Reported by RAId_DbS. The report format of RAId_DbS contains a header portion that 
shows important relevant information pertinent to the score statistics. The Goodness-of-fit of the score model is reported. 
Basically, it represents how well the score model, be theoretically derived or assumed, agrees with the cumulated score histo-
gram. Also reported is a quantity called the model P-value, which documents the likelihood for the correlation strength 
between the model score distribution and the score histogram to come out of random matching. In the report table, the first 
column shows the E-values and the second column shows the P-values. The protein IDs, shown in fifth column, also serves as 
the links to the proteins containing the reported peptide. The sixth column contains information of novel SAPs, if the reported 
peptide contains a novel SAP. The seventh column shows disease information, if the reported peptide contains disease related 
SAPs or PTMs.
Goodness-of-Fit Model 0.996
Model Correctness P-value 1.54e-14
Degrees of Freedom Fit 10
Average Weighted Peaks Used per Peptide 7.91
E-value P-value Peptide
Molecular Weight
(Da)
Protein ID Novel SAP Disease
4.438e-11 2.441e-14 KQNCDQFEKLGEYGFQNALIVR 2472.180 (412;NP_851335 P02769)
6.712e+00 3.692e-03 RWLARPYYFLSALLSAAFLLVR 2470.380 (19;NP_001015558)
8.750e+00 1.692e-02 KIEISQNDVLEVIEANVFSNLPK 2471.270 (74;NP_776486 P35376)
1.086e+01 2.966e-03 RLEGPLATMRSTGPRAVLYEGPVR 2470.300 (299;XP_613471)
1.105e+01 2.138e-02 KWSGENSYFINGDISSLELGGGGGR 2472.100 (929;XP_614418)
1.231e+01 2.381e-02 RSSLCWLLTLLLILATAAQGQPTR 2469.370 (2;NP_776859 Q9GKN8)
1.559e+01 2.927e-03 KKNSLKEDHEETKLSLSDIETR 2472.220
(278;XP_001251846)(293;
XP_879720)
1.594e+01 4.353e-03 KQLSKTQEDLEAQVTLVENLRR 2470.310 (230;NP_001019707)
1.685e+01 9.266e-03 KWQEECEEGEGRTIIHCLNGGGR 2473.070 (1360;XP_586668)
1.905e+01 3.576e-03 REINDVFEGRRGEKYGYLSLPK 2470.230
(520;XP_001251316)(520;
XP_877836)BMC Genomics 2008, 9:505 http://www.biomedcentral.com/1471-2164/9/505
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(the pool of peptides regardless of whether the N-terminal
cleavage is correct) versus a hit from a smaller effective
database (the pool of peptides with correct N-terminal
cleavage only).
RAId_DbS Augmentation
The same statistical approach is used in the augmented
RAId_DbS. Different counters are set up to record the
numbers of scored peptides in different categories. As a
specific example, when novel SAPs are allowed,
RAId_DbS creates a new counter, Cnovel_sap, to total the
number of scored peptides with a novel SAP. This is in
general a much larger number than other counters. When
we calculate the E-value associated with a peptide hit that
contains a novel SAP, we multiply the peptide's P-value by
the sum of existing counters with Cnovel_sap included. How-
ever, in the same search, for a peptide without novel SAP,
its  E-value is obtained by multiplying the peptide's P-
value by the sum of existing counters excluding Cnovel_sap.
The same approach is applied to PTMs and other annota-
tions.
Below we briefly sketch how RAId_DbS deals with the
presence of annotated SAPs, PTMs as well as novel SAPs.
In our database format, annotated SAPs and PTMs are
inserted right after the site of variation, see Figures 1 and
4. From this point on, we will call sites containing anno-
tated SAPs/PTMs variable sites and sites without anno-
tated SAPs/PTMs unvaried sites. When searching the
database for peptides with parent ion mass 1500 Da, for
example, RAId_DbS sums the masses of amino acids
within each possible peptide to see if the total mass is
within 3 Da (the default parent ion mass error range of
RAId_DbS) of 1500 Da. At this stage, a variable site has,
instead of a fixed mass, several possible masses depending
on the number of annotated SAPs/PTMs at that site. A
peptide that covers some variable sites therefore has sev-
eral masses, each corresponding to a specific arrangement
of SAPs/PTMs. If some of these masses happen to be
within 3 Da of 1500 Da, RAId_DbS will score this peptide
with corresponding annotated SAPs/PTMs that give rise to
the proper masses. If none of these masses are within the
allowed molecular mass range, that peptide will not be
scored. It is worth pointing out that the default mass error
tolerance (3Da) may be changed by the user on the web
page while submitting a query spectrum to search.
Note that our approach is computationally efficient in
terms of mass selection. For example, if a peptide contains
a variable site, one first sum the amino acid masses of
unvaried sites to obtain munv. One then checks whether
the masses associated with the variable site adding to munv
will fall in the desirable mass range. This approach is par-
ticularly powerful when there is more than one variable
site in the peptide considered. As demonstrated in Figure
1 and its caption, the combinatorics associated with two
variable sites result in only a longer list of possible masses
to be added to munv. This should be contrasted with meth-
ods that incorporate SAPs via appending polymorphous
peptides to the end of the primary sequence. In the latter
approach, the program needs to do the mass sum multiple
times, repeating the mass sum of unvaried sites, and thus
may slow down the searches.
Despite RAId_DbS's strategic advantage, introduction of
SAPs/PTMs does increase the complexity of the algorithm.
Therefore, during the searches RAId_DbS only considers
for each candidate peptide to have up to two annotated
SAPs and up to five annotated PTMs. To facilitate discov-
ery, RAId_DbS also permits novel SAPs, but limited to one
novel SAP per not-yet-annotated peptide, meaning peptides
that do not contain any annotated SAPs/PTMs. This is
because the introduction of novel SAP largely expands the
search space, and if one allows novel SAPs within peptides
already documented with SAPs/PTMs, the search space
expansion will be even larger and may render the search
intractable. Currently, the novel SAP search is expedited
via a pre-computed list of amino acid mass difference. As
an example, assume that one is searching for a peptide
with parent ion mass 1500 Da, and a not-yet-annotated
candidate peptide has mass 1477 Da, 23 Da smaller than
the target mass. It happens that 23 Da is also the mass dif-
Structure of Enhanced Database Figure 4
Structure of Enhanced Database. Consensus protein sequences NP_775259 (first line, residues 480 – 510 shown) and 
NP_076410 (second and third lines, residues 81 – 170 shown) are used as examples to demonstrate the structure of our 
sequence file, part of the enhanced database. A "[" character is always inserted after the last amino acid of each protein to 
serve as a separator. Annotated SAPs and PTMs associated with an amino acid are included in a pair of angular brackets follow-
ing that amino acid. SAPs are further enclosed by a pair of curly brackets while PTMs are further enclosed by a pair of round 
brackets. Amino acid followed by two zeros indicates an annotated SAP. Every annotated PTM has a two-digit positive integer 
that is used to distinguish different modifications.
...RTLVGLCKLG SAGGTD {H00} YGLR QFAEGSTEKL ....................................[
...IEYISYFWVI GN (N08,N09,N10,N11,N12) QSSMWFAT SLSIFYFLKI ANFSNYIFLW LKSRTNMVLP
FMIVFLLISS LLNFAYIAKI LNDYKT {M00} KN (N08,N09,N10,N11,N12) DT VWDLNMYKSE ...[BMC Genomics 2008, 9:505 http://www.biomedcentral.com/1471-2164/9/505
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ference between Tryptophan and Tyrosine, and if the can-
didate peptide contains a Tyrosine, RAId_DbS will replace
that Tyrosine with a Tryptophan and score the new pep-
tide. If the candidate peptide contains two Tyrosines,
RAId_DbS will replace one Tyrosine at a time with a Tryp-
tophan and score both of the new peptides. It is evident
that the complexity grows fast if one were to allow for two
novel SAPs or more per peptide.
Results and Analysis
In this section, we first report the status of our ongoing
construction of and real examples of enhanced organis-
mal databases. Comparison to related approaches will
also be provided, followed by a few example studies.
Database Construction Status
As summarized in Table 1, we have finished constructing
databases for 17 organisms. Note that disease information
is included only in the human database. Within the
enhanced human database, we have 123,464 SAPs and
81,984 PTMs. Of those SAPs and PTMs, 15,787 have dis-
ease associations. In each enhanced organismal database,
the consensus sequences (after information-preserved
sequence clustering) are fused into a single string sepa-
rated by the "[" character. This long string is stored in a file
with a suffix ".seq" or simply called the sequence file. The
sequence identifiers and other annotations are relegated
into a file with a suffix ".def" or called a processed defini-
tion file. The processed definition file is only used in the
final reporting stage of the search. A typical protein
sequence in an enhanced sequence file carries with it
annotated SAPs and PTMs in a simple format. In Figure 4
we show two consensus sequences containing SAPs/
PTMs. The entries, associated with these two consensus
sequences, in the processed definition file are shown in
Table 2.
The format of our sequence file minimizes redundancy in
searches. For example, if a single site contains two SAPs,
construction method proposed by Schandorff et. al. [11]
will demand two almost identical partial sequences, each
may be several tens of amino acids in length, be appended
after the primary sequence, while in our case it only takes
up a few additional bytes. The compactness of our data-
base becomes obvious when incorporating the informa-
tion of two nearby sites, each containing several
annotated SAPs and PTMs, into the database. In our con-
struction, we only need a few additional bytes. But in
other approaches, it may introduce an appreciable expan-
sion due to including/excluding and pairing of different
variations at both sites along with the flanking peptides,
see Figure 5 for an illustration. Another key difference
between our method and other database methods is that
we do not need to limit the number of enzymatic miscle-
avages.
When needed and when using the standalone version of
RAId_DbS, users may create their own databases with
user-specific knowledge input. The user will provide both
a FASTA file containing sequences to be included and a
separate information file documenting the modifications
and annotation associated with variable sites of each
sequence. The format is illustrated in Figure 6. Through
our Perl script UserDB.pl, the flat information file -con-
Illustration of Minimum Redundancy of our Database Figure 5
Illustration of Minimum Redundancy of our Database. In this example, the sequence has two nearby variable sites with 
residues R and M colored in red. Residue R may be replaced by a residue W due to a possible SAP; while residue M may be 
replaced by a residue V or an acetylated methionine (M01, in our notation) due to respectively a possible SAP or PTM. This 
information is encoded in our sequence file as shown in part (A). To encode the same information, method proposed in refer-
ence [11] would have up to five additional highly similar peptides separated by a letter "J" appended to the end of the primary 
sequence, see part (B). Here a lower case m is used to denote the acetylated methionine. Another key difference in the two 
methods shown above is on the limit of allowed number of enzymatic miscleavages. In our method, there is no limit on the 
number of allowed miscleavages, while in other approaches, the number of miscleavages is usually set to below a certain 
threshold. As an example, in our method, the variant peptides SPVCTWLILGSKEQTVTIR and SPmCTWLILGSKEQTVTIR are 
already included in (A). But in the approach of reference [11], in order to allow consideration of this variant peptide, one 
either needs to additionally append this peptide or to have much longer flanking peptides than shown in (B).
(A)
...LEVRQGTLQPLVR {W00} DRSPM {V00}(M01) CTWLILGSKEQTVTIR ...
(B)
...LEVRQGTLQPLVRDRSPMCTWLILGSKEQTVTIR ......
JQGTLQPLVRSRSPVCTWLILGSKJQGTLQPLVRSRSPmCTWLILGSKJQGTLQPLVWSRSPMCTWLILGSK
JQGTLQPLVWSRSPVCTWLILGSKJQGTLQPLVWSRSPmCTWLILGSKBMC Genomics 2008, 9:505 http://www.biomedcentral.com/1471-2164/9/505
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taining the protein accession numbers, detailed SAP/PTM
information, and disease associations- is processed
together with the FASTA file provided by the user to gen-
erate the user-specific ".seq" file and ".def" file which are
suitable for searches using RAId_DbS. If one wishes to add
additional SAPs or PTMs, one simply updates both the
FASTA sequence file as well as the flat information file and
rerun the Perl script. When reporting a hit with annotated
SAPs or PTMs, RAId_DbS automatically reports the corre-
sponding detailed information and disease association if
it exists.
Examples
Using a tandem mass (MS2) spectrum taken from the pro-
file dataset described in reference [18], we illustrate in
Table 3 two search results in the human protein database
An Example of user-specific database construction Figure 6
An Example of user-specific database construction. To construct a user-specific database, the user needs to provide a 
FASTA file containing sequences of interest and a flat information file documenting the SAPs/PTMs and disease information that 
the user wishes to consider. In this example, Id_Seq1 and Id_Seq2 represent sequence identifiers. In the information file, the 
format is as follows. First column indicates residue position; second column specifies whether the modification is a SAP or 
PTM; third column records the original residue in the sequence at position specified in the first column; fourth column consists 
of either a list of possible SAPs (L, I, V) or a list of possible PTMs (N08, N09, N10, N11, N12); fifth column documents disease 
names, if any, associated with the modifications at the specified positions. The user may then run our script, UserDb.pl, to gen-
erate the appropriate ".seq" and ".def" files suitable for searching using RAId_DbS. More detail can be found in the help page 
http://www.ncbi.nlm.nih.gov/CBBresearch/qmbp/RAId_DbS/raid_help.html of RAId_DbS.
Fasta file example:
>Id_Seq1 Isoform alpha 
MLLATLLLLLLGGALAHPDRIIFPNHACEDPPAVLLEVQGTLQRPLVRDSRTSPANCTWLILGSKEQTVT
IRFQKLHLACGSERLTLRSPLQPLISLCEAPPSPLQLPGGNVTITYSYAGARAPMGQGFLLSYSQDWLMC
LQEEFQCLNHRCVSAVQRCDGVDACGDGSDEAGCSSDPFPGLTPRPVPSLPCNVTLEDFYGVFSSPGYTH
...
>Id_Seq2 Isoform beta 
MLLATVVVVTSGGALAHPDRIIFPNHACEDPPAVLLEVQGTLQRPLVRDSRTSPANCTWLILGSKEQTVT
IRFQKLHLACGSERLTLRSPLQPLISLCEAPPSPLQLPGGNVTITYSYAGARAPMGQGFLLSYSQDWLMC
LQEEFQCLNHRCVSAVQRCDGVDACGDGSDEAGCSSDPFPGLTPRPVPSLPCNVTLEDFYGVFSSPGYTH
...
         User knowledge file example:
>Id_Seq1
48 SAP R W deadly cancer
56 PTM N N08,N09,N10,N11,N12
111 PTM N N08,N09,N10,N11,N12
139 SAP M V diabetes
193 SAP N L,I,V
193 PTM N N08
299 PTM N N08,N09,N10,N11,N12
365 SAP A T color blind 
434 SAP S C,T,V,P insulin dependent diabetes
558 SAP R H,P,W
>Id_Seq2
48 SAP R W deadly cancer
56 PTM N N08,N09,N10,N11,N12
111 PTM N N08,N09,N10,N11,N12
139 SAP M V diabetes
193 SAP N L,I,V
193 PTM N N08
299 PTM N N08,N09,N10,N11,N12
365 SAP A T color blind 
434 SAP S C,T,V,P insulin dependent diabetes
558 SAP R H,P,WBMC Genomics 2008, 9:505 http://www.biomedcentral.com/1471-2164/9/505
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with the annotated SAPs and PTMs turned off (a) and on
(b) respectively. In case (a), the best hit is a false positive
with E-value about 0:11 implying that one probably ends
up declaring no significant peptide hit for this spectrum.
In case (b), however, the best hit is a true positive (a pep-
tide from human transferin with an annotated SAP) with
E-value about 4.0 × 10-7. This example shows that if prop-
erly used, allowing SAPs/PTMs may increase the peptide
identification rate. That is, it may be fruitful to turn on the
SAPs/PTMs when a regular search returns no significant
hit. Turning on SAPs/PTMs without first searching with
SAPs/PTMs turned off, however, may cause a loss of sensi-
tivity due to the increase of search space.
It is commonly believed that when searching a large data-
base, sensitivity is severely lost. This is particularly true if
the E-value for every hit is obtained by multiplying the
peptide's P-value by the same number (e.g. the largest
effective database size) regardless of the category that pep-
tide belongs to. As we have explained earlier, RAId_DbS
does not do that. It uses a method equivalent to Bonfer-
roni correction. We use E-values to rank peptide hits and
each peptide's E-value is obtained by multiplying its P-
value by the corresponding size of the effective database
that the peptide belongs to. Consequently, to be equally
significant, peptide hits falling in a category that has a
large effective database size need to have smaller P-values
than those of peptide hits falling in a category that has a
small effective database size.
Nevertheless, even with such a strategy one can never
guarantee to bypass the sensitivity loss problem associ-
ated with searching a large database.
Although we have shown [19] as a preliminary study that
no appreciable loss of sensitivity is found using the 54
training spectra of PEAKS [20], the number of spectra
there is too small to ensure our observation to be statisti-
cally robust. We therefore set out to use spectra from a
larger collection of human proteins [21], henceforth
referred to as the Aurum dataset, to test the severity of sen-
sitivity loss when expanding the search space via turning
on SAPs/PTMs and novel SAPs. The Aurum data [21] is a
set of MS/MS spectra generated in an ABI 4700 MALDI
TOF/TOF instrument. The sample is a mixture of 246
human proteins that were individually purified and tryp-
tically digested. This data was developed to be a standard
reference for the purpose of testing or training new algo-
rithms.
In Figure 7, we show the Receiver Operating Characteristic
(ROC) curves when analyzing the Aurum dataset [21]
which contains 9977 spectra from a selection of human
proteins. In each of the two panels of Figure 7, there are
three ROC curves corresponding to regular searches with-
out SAPs/PTMs, searches allowing annotated SAPs/PTMs,
and searches allowing both annotated SAPs/PTMs as well
as novel SAPs. Although there seems to be no perform-
ance degradation judging from the sensitivity versus 1-
specificity plot (panel (A)), we do see mild degradation in
terms of the cumulative number of true positives found
using a fixed number of false positives as the threshold
(panel (B)). Compared to regular searches, turning on
SAPs/PTMs and novel SAPs results in a larger number of
false hits which pulls the ROC curve towards the left end
upon normalization. This may partially explain why turn-
ing on SAPs/PTMs and novel SAPs does not introduce an
appreciable loss in sensitivity.
Table 3: Example search results of augmented RAId_DbS
(a) E-value P-value Peptide Mol. Wt. Protein ID Novel SAP Disease
1.184e-01 1.744e-05 RTKLKDC...KIAR 2897.500 (NP_114412;...;Q9H2L5) disabled
AA A A A A A
4.084e+00 9.345e-03 KQQELAA...VSSR 2898.520 (NP_072096;...;O75420) disabled
(b) E-value P-value Peptide Mol. Wt. Protein ID Novel SAP Disease
3.977e-07 1.834e-10 KsVEEYANCHLAR 1448.650 (NP_001054;...;P02787) disabled
4.779e-01 2.205e-04 KsVqEYANCHLAR 1447.670 (NP_001054;...;P02787) disabled
AA A A A A A
7.524e-01 3.470e-04 R<MNAsMVWAQAAR 1448.720 (NP_000337;...;P48436) disabled {(<;2;108;Campomelic dysplasia 
(CMD1) [MIM:114290])(s;6;...)}
In this example, for the spectrum considered, RAId_DbS performs searches assuming the parent ion to have charge +1, +2, +3. The search results 
are then pooled together to form a single result ranked by E-values. This is why for the same spectrum RAId_DbS may report peptide hits with 
very different masses. In part (a) ((b)), searches were done with annotated SAPs and PTMs turned off (on). The lowercase letters in the peptide 
indicate SAPs. A novel SAP, if present and enabled in the searches, will be specified in the column headed by Novel SAP. Note that in the disease 
related annotation, there are four fields separated by three semicolons. The first field, a lower case amino acid letter, indicates the SAP; second 
field, an integer, indexes the SAP position in the peptide; the third field, an integer, indexes the SAP position in the protein; the fourth field shows 
the annotated disease association.BMC Genomics 2008, 9:505 http://www.biomedcentral.com/1471-2164/9/505
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Discussion
From analyzing the Aurum dataset using different search
spaces, we confirmed that the number of true positives
found at a false positive threshold may decrease if the
search is done in a larger search space, i.e., with novel
SAPs and/or annotated SAPs/PTMs unconditionally ena-
bled. This indicates that it is not productive to search with
the annotated SAPs/PTMs and novel SAPs enabled all the
time. We recommend the user to turn on these features
conditionally. For example, if a spectrum does not receive
any significant hit from a regular search, one may then
allow the annotated SAPs/PTMs. If the search still returns
no significant hit, one may then turn on novel SAPs in the
search. It is in this context that one may increase the
number of peptides identified.
It has not escaped our attention that the ROC curves
shown in panel (B) of Figure 7 do not rise steeply as one
typically sees. This, however, may be caused by the pres-
ence of contaminants during protein purification that
introduced peptides not belonging to the target proteins.
Since our main purpose is to study the relative sensitivity
degradation upon enlarging the search space, we do not
delve into the investigations of peptide hits with low E-
values but not subsequences of target proteins.
The processed definition files associated with our
enhanced databases contain consolidated information in
a tab delimited format, allowing easy information extrac-
tion by others who are interested in utilizing this informa-
tion in different contexts. While the information
contained in our enhanced databases are helpful in terms
of forming hypotheses and narrowing down the scope of
investigation, it should be used with caution because sci-
entific literature, consisting of coherent information, also
contains conflicting information. Therefore the reported
disease association should not be used as a diagnosis
report but only be used as a reference for further investiga-
tion. In particular, from clinical application point of view,
patients and clinical scientists may benefit from such
information as it suggests possibilities of diseases that
may otherwise be overlooked.
It is our plan to continue construction of enhanced data-
bases for additional organisms. Although little disease
information exists for most organisms other than human,
we will include it in our databases when more informa-
tion becomes available. For example, the NCBI's Online
Mendelian Inheritance in Animals OMIA, http://
www.ncbi.nlm.nih.gov/ contains information of genes,
inherited disorders and traits in animal species (other
than human and mouse). We plan to integrate this infor-
mation into our organismal databases in the near future.
Under our database format, it is also possible to incorpo-
rate other information such as protein fusions, 3D protein
structures, drug-binding/active sites, cross-linking sites,
ROC curves obtained from different search modes Figure 7
ROC curves obtained from different search modes. ROC curves for three different search modes employed when run-
ning RAId_DbS using the Aurum dataset composed of 9977 spectra. In panel (A) curves are shown in sensitivity versus (1-spe-
cificity), while in panel (B) the cumulative number of true positives versus the cumulative number of false positives are shown. 
In panel (B), the increase in the number of false positives coming from annotated SAPs/PTMs (red curve) and with novel SAPs 
(blue curve) is anticipated due to a larger search space compared to searches done within the standard database only. The 
larger total number of false positives found in the latter methods, however, will push the ROC curves leftwards upon normal-
izing to 1-specificity.
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and isoforms. We are currently assessing which additional
information to include next. It is also worth pointing out
that our database compactification via clustering has an
advantage in reducing search time.
Without collapsing identical and almost identical pro-
teins, one is bound to score identical peptides multiple
times. Our compactification strategy minimizes redun-
dant searches of this sort. This reduction of redundancy
will become important when exploring unrestricted PTM
searches.
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